Mesothelioma Clinical Trials Now Back on Course
A number of treatment centers, such as Brigham and Women’s Hospital in Boston, delayed mesothelioma clinical trials at the start of the pandemic. Others, such as the Pacific Mesothelioma Center in Los Angeles, continued screening patients, but on a limited basis.
Now, many mesothelioma clinical trials are resuming regular screening and enrollment measures for mesothelioma patients at most sites.
And thanks to measures put in place by the National Cancer Institute, medical professionals have been able to make safe and effective adjustments to clinical trial visits and study activities.
The NCI has worked with institutional review boards and trial sponsors to provide more flexibility for the timing of patient tests and assessments.
Currently, over 100 active clinical trials across North America are enrolling mesothelioma patients. That number will continue to grow as more treatment centers adjust to phased reopenings and implement new methods of treating participants safely.
Source: National Cancer Institute